Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06415201
Other study ID # HI23C0315
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2024
Est. completion date December 31, 2027

Study information

Verified date May 2024
Source Seoul National University Hospital
Contact Sunhyung Lee, M.D.
Phone 82-2-2072-3767
Email total3562@naver.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aims of this study are developments of mental health care services for cancer patients based on interactive artificial intelligence. To do these things, survey of unmet medical needs and data collection of clinical interviews will be done, and newly developed assessment and intervention scenarios will be simulated to cancer patients group.


Description:

A total of 20 people will be recruited from 3 institutions to investigate unmet medical needs. Based on the needs, we will develop scenarios to assess, classify, explain and conduct supportive interviews. We plan to develop a stress self-management scenario that helps manage lifestyle habits and provides meditation-based cognitive therapy. For moderate to severe distress, we plan to develop scenarios to link medical care and manage suicide risk. We plan to conduct interviews with a total of 300 people to collect clinical interview data for scenario development.


Recruitment information / eligibility

Status Recruiting
Enrollment 360
Est. completion date December 31, 2027
Est. primary completion date December 31, 2025
Accepts healthy volunteers No
Gender All
Age group 19 Years and older
Eligibility Inclusion Criteria: - Patients diagnosed with malignant tumor and undergoing treatment, or patients undergoing follow-up after completing curative treatment Exclusion Criteria: - Patients unable to consent to research or be interviewed due to cognitive decline

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Interactive Artificial Intelligence
scenario based AI to assess, classify, explain and conduct supportive interviews

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul

Sponsors (3)

Lead Sponsor Collaborator
Seoul National University Hospital Dongguk University Medical Center, Eulji University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Distress Distress Thermometer baseline
Primary Quality of life measurement WHOQOL baseline
Primary Stress PSS-10 (Perceived Stress Scale) baseline
Primary Self-esteem K-RES (Korean version of Rosenberg Self-Esteem Scale) baseline
Primary Acceptance of Disability Acceptance of Disability Scale baseline
Primary Pain measurement PBPI (Pain belief & Perception inventory) baseline
Primary Insomnia ISI (Insomnia Severity Index) baseline
Primary Quality of sleep PSQI (Pittsburgh Sleep Quality Index) baseline
Primary Fatigue FACIT-Fatigue (Functional Assessment of Chronic Illness Therapy) baseline
Primary Anxiety & Depression HADS (Hospital anxiety and depression scale) baseline
Primary Suicidality MINI-Plus (Mini-international Neuropsychiatric interview) baseline
Primary Fear of Disease Progression FOP-SF (Fear of Disease Progression Short Form) baseline
Primary Social Support MOS Social support Survey baseline
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients